Clinical prospective study to investigate efficacy of WT1 peptide (PepTivator(R))-pulsed dendritic cell vaccination therapy
Phase of Trial: Phase II
Latest Information Update: 05 Dec 2014
Price : $35 *
At a glance
- Drugs WT1 peptide-loaded dendritic cell vaccine (Primary)
- Indications Cancer; Solid tumours
- Focus Therapeutic Use
- 04 Dec 2014 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan record.
- 09 Apr 2013 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan record.
- 07 Jan 2013 New trial record